» Articles » PMID: 24152995

Peroxiredoxin I and II in Human Eyes: Cellular Distribution and Association with Pterygium and DNA Damage

Overview
Publisher Sage Publications
Specialty Biochemistry
Date 2013 Oct 25
PMID 24152995
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxiredoxin I and II are both 2-Cys members of the peroxiredoxin family of antioxidant enzymes and inactivate hydrogen peroxide. On western blotting, both enzymes appeared as 22-kD proteins and were present in the sclera, retina and iris. Immunohistochemistry showed strong cytoplasmic labeling in the basal cells of the corneal epithelial layer and the corneoscleral limbus. The melanocytes within the stroma of the iris and the anterior epithelial cells of the lens also showed strong cytoplasmic labeling. The fibrous structure of the stroma and the posterior surface of the ciliary body were also labeled. There was also strong labeling for both enzymes in the photoreceptors and the inner and outer plexiform layers of the retina. There was increased labeling of peroxiredoxin I and II in pterygium. In normal conjunctiva and cornea, only the basal cell layer showed labeling for peroxiredoxin I and II, whereas, in pterygia, there was strong cytoplasmic labeling in most cells involving the full thickness of the epithelium. Co-localization of the DNA oxidation product 8-hydroxy-2'-deoxyguanosine antibody with the nuclear dye 4',6'-diamidino-2-phenylindole dihydrochloride indicated that the majority of the oxidative damage was cytoplasmic; this suggested that the mitochondrial DNA was most affected by the UV radiation in this condition.

Citing Articles

Oxidative Stress in the Protection and Injury of the Lacrimal Gland and the Ocular Surface: are There Perspectives for Therapeutics?.

Lemos C, Silva L, Faustino J, Fantucci M, Murashima A, Adriano L Front Cell Dev Biol. 2022; 10:824726.

PMID: 35359431 PMC: 8963457. DOI: 10.3389/fcell.2022.824726.


Phytochemical Profile and Antioxidant and Antiproliferative Activity of on Pterygium Fibroblasts.

Lopez-Montemayor P, Zavala J, Montalvo-Parra M, Guerrero-Ramirez G, Mayolo-Deloisa K, Enriquez-Ochoa D Evid Based Complement Alternat Med. 2021; 2021:5814221.

PMID: 34707671 PMC: 8545536. DOI: 10.1155/2021/5814221.


Is the Conjunctiva a Potential Target for Advanced Therapy Medicinal Products?.

Diebold Y, Garcia-Posadas L Pharmaceutics. 2021; 13(8).

PMID: 34452098 PMC: 8402183. DOI: 10.3390/pharmaceutics13081140.


Systemic oxidative stress biomarkers in patients with vitreomacular traction syndrome.

Kilic D, Kocer D, Sirakaya E, Kucuk B, Vural E, Guven S Int Ophthalmol. 2021; 41(11):3789-3796.

PMID: 34259960 DOI: 10.1007/s10792-021-01949-0.


HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.

Leyk J, Daly C, Janssen-Bienhold U, Kennedy B, Richter-Landsberg C Cell Death Dis. 2017; 8(8):e3028.

PMID: 29048427 PMC: 5596594. DOI: 10.1038/cddis.2017.415.


References
1.
Perra M, Maxia C, Corbu A, Minerba L, Demurtas P, Colombari R . Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol Vis. 2006; 12:1136-42. View

2.
Peng M, Tsai Y, Chiang C, Huang Y, Chou M, Yeh K . CYP1A1 protein activity is associated with allelic variation in pterygium tissues and cells. Mol Vis. 2012; 18:1937-43. PMC: 3413426. View

3.
Hasanova N, Kubo E, Kumamoto Y, Takamura Y, Akagi Y . Age-related cataracts and Prdx6: correlation between severity of lens opacity, age and the level of Prdx 6 expression. Br J Ophthalmol. 2009; 93(8):1081-4. DOI: 10.1136/bjo.2008.152272. View

4.
Lee W, Choi K, Riddell J, Ip C, Ghosh D, Park J . Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem. 2007; 282(30):22011-22. DOI: 10.1074/jbc.M610330200. View

5.
Ucakhan O, Kanpolat A, Elgun S, Durak I . The role of oxidative mechanisms in the etiopathogenesis of pterygium: a preliminary study. Ophthalmologica. 2008; 223(1):41-6. DOI: 10.1159/000167020. View